Search
Menu
PI Physik Instrumente - Revolution In Photonics Align ROSLB 3/24

Hybrigenics

Facebook X LinkedIn Email
Biopharmaceutical company Hybrigenics, based in Paris, has signed a contract as part of the European Union research project Masterswitch. The company will receive more than €400,000 over the first two years of the five-year agreement, which will enable it to develop a high-throughput assay and attempt to identify small-molecule inhibitors of a protein reaction found in chronic inflammatory diseases.
Meadowlark Optics - Building system MR 7/23

Published: May 2009
BiophotonicsHybrigenicsMasterswitchNews & Features

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.